Showing results (311-320 of 419) with videos related to

Sort By:
Pageof 42
Cancer Medicine|November 25, 2016
Survival of patients with metastatic leiomyosarcoma: the MD Anderson Clinical Center for targeted therapy experienceZhijie Wang, Naiyi Shi, Aung Naing, et al.
Scientific Reports|October 18, 2016
Evaluation of Novel Targeted Therapies in Aggressive Biology Sarcoma Patients after progression from US FDA approved TherapiesVivek Subbiah, Kenneth R Hess, Muhammad Rizwan Khawaja, et al.
Experimental Hematology & Oncology|December 30, 2021
Selinexor in combination with standard chemotherapy in patients with advanced or metastatic solid tumorsKyaw Z Thein, Sarina A Piha-Paul, Apostolia Tsimberidou, et al.
Scientific Reports|May 24, 2022
Clinical characteristics and outcomes of phase I cancer patients with CCNE1 amplification: MD Anderson experiencesShuyang Yao, Funda Meric-Bernstam, David Hong, et al.
JCO Precision Oncology|October 16, 2018
Clinical Use of Precision Oncology Decision SupportAmber Johnson, Yekaterina B Khotskaya, Lauren Brusco, et al.
Clinical Breast Cancer|July 29, 2014
Analysis of MET genetic aberrations in patients with breast cancer at MD Anderson Phase I unitDebora de Melo Gagliato, Denis L Fontes Jardim, Gerald Falchook, et al.
Oncotarget|May 10, 2014
Unique molecular signatures as a hallmark of patients with metastatic breast cancer: implications for current treatment paradigmsJennifer J Wheler, Barbara A Parker, Jack J Lee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 6, 2021
First-in-Human Phase I Study of ABBV-085, an Antibody-Drug Conjugate Targeting LRRC15, in Sarcomas and Other Advanced Solid TumorsGeorge D Demetri, Jason J Luke, Antoine Hollebecque, et al.
Oncology and Therapy|March 19, 2024
The Impact of Prior Single-Gene Testing on Comprehensive Genomic Profiling Results for Patients with Non-Small Cell Lung CancerMary K Nesline, Vivek Subbiah, Rebecca A Previs, et al.
Oncology|November 2, 2016
Post-Discharge Survival Outcomes of Patients with Advanced Cancer from the University of Texas MD Anderson Cancer Center Investigational Cancer Therapeutics (Phase I Trials) Inpatient UnitHolly Kinahan, Abhishek Maiti, Kenneth Hess, et al.
Pageof 42